Use of the plasma triglyceride/high-density lipoprotein cholesterol ratio to identify cardiovascular disease in hypertensive subjects
- 1 October 2014
- journal article
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 8 (10) , 724-731
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adultsJournal of Lipid Research, 2013
- Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR)Acta Diabetologica, 2013
- Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high‐density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteriaJournal of Internal Medicine, 2013
- Within-visit blood pressure variability: relevant factors in the general populationJournal of Human Hypertension, 2012
- Relation Among the Plasma Triglyceride/High-Density Lipoprotein Cholesterol Concentration Ratio, Insulin Resistance, and Associated Cardio-Metabolic Risk Factors in Men and WomenThe American Journal of Cardiology, 2012
- Within‐Visit Variability of Blood Pressure and All‐Cause and Cardiovascular Mortality Among US AdultsThe Journal of Clinical Hypertension, 2012
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) StudyHypertension, 2007
- Is There a Simple Way to Identify Insulin-Resistant Individuals at Increased Risk of Cardiovascular Disease?The American Journal of Cardiology, 2005
- The insulin resistance syndromeCurrent Atherosclerosis Reports, 2003